CLEARLAKE TECHNOLOGY LIMITED
Company number 13698287 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
CLEARLAKE TECHNOLOGY LIMITED - Analysis Report
Company Number: 13698287
Analysis Date: 2025-07-19 12:05 UTC
Financial Health Assessment of Clearlake Technology Limited as of 31 March 2024
1. Financial Health Score: D
Explanation:
Clearlake Technology Limited exhibits significant financial distress indicators, primarily due to a high level of net current liabilities relative to current assets, and persistent negative shareholders' funds. The company has negative working capital and equity, which are symptoms of financial strain. However, the going concern note indicates shareholder support, which somewhat mitigates immediate insolvency risk but does not improve operational health. Thus, a "D" grade reflects a distressed but still operational condition reliant on external support.
2. Key Vital Signs
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Current Assets | 24,781 | Low liquidity base but modest increase from prior year |
| Cash | 9,962 | Limited cash reserves to cover short-term obligations |
| Debtors | 14,819 | Significant proportion of assets tied up in receivables |
| Current Liabilities | 77,457 | High short-term obligations indicating liquidity pressure |
| Net Current Assets | -52,676 | Negative working capital, a strong symptom of distress |
| Shareholders’ Funds | -52,676 | Negative equity indicating accumulated losses and capital deficit |
| Turnover | Not disclosed | Unable to assess revenue trends due to lack of P&L data |
| Employee Count | 0 | No employees reported, possibly indicating minimal operations |
| Going Concern Status | Supported | Accounts prepared on going concern basis due to shareholder backing |
Interpretation of Vital Signs:
- The negative net current assets (working capital) is a critical red flag, signaling that the company cannot meet its short-term liabilities from its short-term assets alone. This is akin to a patient showing symptoms of dehydration—an urgent liquidity deficit.
- The negative shareholders’ funds reflect cumulative losses or capital injections insufficient to restore equity, indicating chronic financial weakness, similar to a patient with a weakened immune system.
- The cash balance is low relative to liabilities, showing limited "healthy blood flow" of funds to sustain operations without external injections.
- The absence of employees could mean the company is not actively trading or is heavily reliant on third parties or group support.
- The directors’ note about shareholder support is critical—it acts like a life-support system, keeping the business solvent despite poor internal finances.
3. Diagnosis: Financial Condition and Business Health
Clearlake Technology Limited is currently in a state of financial distress, characterized by:
- Negative working capital and equity indicating strained liquidity and solvency.
- Growing liabilities far exceeding liquid assets, suggesting difficulty in meeting obligations without external support.
- No staff employed, which may indicate minimal or no operational activity internally.
- The company benefits from the backing of its ultimate shareholder (Clearlake Group Limited), which currently sustains its going concern status.
This financial profile is symptomatic of a business either in a start-up or restructuring phase, heavily reliant on group financing rather than generating independent cash flow. The company faces risks typical of "financial illness" such as potential insolvency if shareholder support ceases, inability to self-fund operations, and limited operational scale.
4. Recommendations: Steps to Improve Financial Wellness
Improve Liquidity Management:
Actively pursue collection of debtors to convert receivables into cash more rapidly. Consider negotiating extended payment terms with creditors to ease short-term cash flow pressures.Capital Injection or Debt Restructuring:
Seek additional equity funding from shareholders or restructure current liabilities to reduce short-term pressure. This is equivalent to providing a transfusion to stabilize the patient’s vitals.Operational Review:
Clarify the company's business model and revenue streams. If the company is dormant or minimally active, consider formal restructuring or alignment with group strategies to restore operational vitality.Cost Control:
Since no employees are reported, ensure any overhead or administrative costs are minimized to reduce cash burn.Enhance Financial Reporting Transparency:
Filing full profit and loss statements and strategic reports will aid stakeholders in diagnosing ongoing issues and planning recovery.Explore Strategic Alternatives:
Evaluate merger, acquisition, or business model pivot options leveraging the parent group’s resources to improve sustainability.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.